Unexplained variation across US nursing homes in antipsychotic prescribing rates. - Test2 - elhamkhani - TriplyDB

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

http://www.wikidata.org/entity/Q33961590

about

Challenge of changing nursing home prescribing culture Perceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care.Psychotropic medications and the transition into care: a national data linkage study.Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials Antipsychotic use among nursing home residents PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol.Use of atypical antipsychotics in nursing homes and pharmaceutical marketing.Perceived intent motivates people to magnify observed harms Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients.Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study A retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents.Comparative safety of antipsychotic medications in nursing home residents A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice Antipsychotic Use in a Diverse Population With Dementia: A Retrospective Review of the National Alzheimer's Coordinating Center Database Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review.Nursing home medical staff organization: correlates with quality indicators.Persistent use of psychotropic drugs in nursing home residents in Norway.Behavioral and Psychological Symptoms of Dementia and Antipsychotic Drug Use in the Elderly with Dementia in Korean Long-Term Care Facilities.Nursing home prices and quality of care - Evidence from administrative data.Family physicians providing regular care to residents in Ontario long-term care homes: characteristics and practice patterns Use of medications of questionable benefit in advanced dementia.Do Nursing Home Chain Size and Proprietary Status Affect Experiences With Care?Antipsychotic Use in Hospitalized Adults: Rates, Indications, and Predictors.The impact of facility characteristics on the use of antipsychotic medications in nursing homes: a cross-sectional study.Prescribing of Psychoactive Drugs for Older People in Nursing Homes: An Analysis of Treatment Culture.Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia Fracture risk in nursing home residents initiating antipsychotic medications.Use of antipsychotics among older residents in VA nursing homes Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses Satisfaction with Massachusetts nursing home care was generally high during 2005-09, with some variability across facilities.Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year period Antipsychotic use in nursing home residents admitted with hip fracture.Prevalence of, and Resident and Facility Characteristics Associated With Antipsychotic Use in Assisted Living vs. Long-Term Care Facilities: A Cross-Sectional Analysis from Alberta, Canada.Antipsychotic use in nursing homes varies by psychiatric consultant.Prescribing for older people in nursing homes: a review of the key issues.Medication administration errors in assisted living: scope, characteristics, and the importance of staff training.Aripiprazole in the treatment of Alzheimer's disease.A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia.Quality of psychopharmacological medication prescribing and mortality in Medicare beneficiaries in nursing homes.Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes.

P2860

Q26865397-C55EB96E-0C46-4771-98B4-BD3FB1EC7AAF Q30397374-6102AF7D-81A5-4AE9-8DDD-51131CB78AFE Q30586082-85BAEB09-E902-42DB-9DDC-AD03605FDAF4 Q33874525-195B52A1-7D83-427B-8400-35C76BF90E73 Q33924005-B535D7F6-222A-4491-87C6-93F4E2975EA7 Q35044533-94C14D3D-C309-41C0-917E-250988AF9CF6 Q35095380-49A42D6E-FB04-4D4E-BB74-D20EE8CC6D51 Q35229399-BF264135-1D9D-42BC-A2FB-73D880F98222 Q35627432-178B8ED8-5BF5-4829-A7D5-0E37E5F770FF Q35775454-AA6A2ECA-753B-48FA-9C5F-25052AC53E24 Q35813455-2D9278F0-61F2-4635-9DB8-4C62D7CA4C42 Q35828059-E3EDFE56-756B-4CA7-9578-9A2FE44C5DC6 Q36091476-B635E591-2DC3-4B9F-B720-7773F9AA71B0 Q36198582-E0C38BED-3CA1-418F-9F65-AD4817C1E8B1 Q36260105-0620DD21-D45D-4336-8A24-852E37AF67D5 Q36271709-33E33299-859F-47C9-ACA6-B1A333A8A509 Q36279048-DB0C68B6-67B7-4BE3-8DBF-C8EBE3EAA20D Q36360262-37EA79AB-41C5-46F7-80A4-8C61E880FADB Q36373744-A1421077-90C1-475C-94AE-12207420DCA7 Q36398776-39493EB2-4EC9-4E97-B63B-19473632279C Q36398853-559E8077-B808-4180-BA6D-E4B2B8229802 Q36578094-42D02888-3511-4D76-9460-D1557102A9C0 Q36603193-D751B8EC-BB91-48B9-A8A5-E34FB8889A30 Q36691503-098DC61E-F7A2-48BE-97B4-918283260790 Q36761466-9B5B157E-B6D7-4043-BBB5-C859973E7F64 Q36826416-8A914DC9-56A6-4594-BD9E-13BEFE42BEFA Q36849936-1FA5E070-88EF-4962-B713-B89E3D61B619 Q37104247-B1D90663-7BF3-4E64-A1BA-96D560FF4233 Q37196381-95F7360B-D5BC-4B51-A5FF-345C9384E5BE Q37201958-C25F77F3-4AEB-413C-860D-BC66FF54FB0F Q37312214-E7D6C466-E5EE-49E7-BB3D-BD538BED66E3 Q37372553-31A5D92E-3CE5-4F60-B6E2-EA8F85BF4FDE Q37575077-D7F76BF0-FA08-4D89-9953-7AA78C09A6AE Q37627895-D4EB74A7-6602-41A0-9F54-0B28647420EE Q37837997-778F4DC7-B8EE-4E59-B855-E935F3AAAB27 Q37886026-CF8A21F0-C701-4AD3-8CEF-A4AB05B092FE Q38076765-3240AE3D-6907-4443-B998-1E3F312B419F Q38150568-D9E45241-B891-471D-9A04-C06954D99090 Q38231604-C9C1C57F-BD17-45AF-BD54-2766B440630A Q38244187-86B5EE68-9723-4875-9073-C69E7B539B73

P2860

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

http://www.wikidata.org/entity/Q33961590

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

@ast

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

@en

type

label

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

@ast

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

@en

prefLabel

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

@ast

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

@en

P1433

Q33961590-EF404462-BC86-4F73-994D-76EA01CCEAD8

P1476

Q33961590-96D4F5A5-CEAA-458B-B773-6B5BC303342D

P2093

Q33961590-6CA5E001-6167-4B2A-A81A-E735BEDF8744

Q33961590-80DB3B88-02D8-4932-AC9F-45B234EE51B6

Q33961590-97C16104-894E-4AA5-83CF-297FBB9C6C1E

Q33961590-CDF10211-8DEF-4CE9-ACE2-8D26CF55DC25

Q33961590-E47642EF-B4BB-454E-B8C7-2B19B8078B95

Q33961590-FDEE9424-447F-498E-8704-57B1A0B83299

P2860

Q33961590-0246045D-C55A-450A-9512-37560008EAF4

Q33961590-11CD9192-E417-4DC1-9268-97CB5494CF56

Q33961590-2A207307-F71C-405B-8201-B721E4AD121B

Q33961590-42C21970-A9CC-43A7-AB3A-E94BDAFAD8B7

Q33961590-4E02A7E9-98CE-4778-9EA0-D69DFCA52109

Q33961590-5414AAEF-3E38-4EF9-B837-0DB29ACF98DC

Q33961590-7013B834-A136-4E18-A3A9-C15F468BA8CD

Q33961590-739236B4-6FBF-460B-9E03-49D0AE145BA6

Q33961590-940D73CC-56B8-40AD-8CB8-94035F31F1B5

Q33961590-9892094F-D196-44FB-963F-1E6D1BA3C49D

P304

Q33961590-40910E49-AC89-4FC5-9B05-F77A4FB0432F

P31

Q33961590-0DBA2449-6284-4414-AEFE-84AE40BE2F9D

P356

Q33961590-32FAD803-37AE-424C-9744-885D486A45D6

P407

Q33961590-CF286EC1-7570-427E-ABDB-29735926BEEF

P433

Q33961590-2E1A1EB6-79AB-4B3F-8A11-1A474DA12CD6

P478

Q33961590-6BED6AC5-F42D-49E2-ADF4-94B9B6355C20

P577

Q33961590-CA8D5DD4-0344-4F5C-9D12-9D92AB7F0B8D

P5875

Q33961590-C7D7B81A-150B-4CB7-95CC-33CCECD938EE

P698

Q33961590-F4A5509E-6485-4166-B054-437F8CF151D2

P932

Q33961590-B2C4B7C7-25A8-4D52-B6A3-F8C60E7F1B0C

P356

ARCHINTERNMED.2009.469

P1433

JAMA Internal Medicine

P1476

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

@en

P2093

Becky A Briesacher

http://www.w3.org/2001/XMLSchema#string

Denys T Lau

http://www.w3.org/2001/XMLSchema#string

Jennifer Tjia

http://www.w3.org/2001/XMLSchema#string

Jerry H Gurwitz

http://www.w3.org/2001/XMLSchema#string

Terry S Field

http://www.w3.org/2001/XMLSchema#string

Yong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature.

Validity and responsiveness of the Minimum Data Set.

Nursing home residents and enrollment in Medicare Part D.

Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges.

Organisational culture and quality of health care

Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies.

National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure survey.

P304

89-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2009.469

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40907791

http://www.w3.org/2001/XMLSchema#string

P698

20065204

http://www.w3.org/2001/XMLSchema#string

P932

2897009

http://www.w3.org/2001/XMLSchema#string